Genetic mutations and risk of breast cancer

July 1997
CMAJ: Canadian Medical Association Journal;07/15/97, Vol. 157 Issue 2, p130
Academic Journal
Reports on the role of genetic mutation in developing breast cancer. How some families and ethnic groups have a higher risk with mutations in the BRCA1 and BRCA2 genes; How the research was focused on subjects of Ashkenazi Jewish ancestry.


Related Articles

  • Role of estrogen receptors in breast cancer studied.  // Cancer News;Spring93, Vol. 47 Issue 1, p19 

    Reports on defective estrogen receptors possible features of breast cancer as cited in a study at the State University of New York at Stony Brook Health Sciences Center. Study on variants or mutations found in breast tumors; Incorrect processing of RNA from estrogen receptors; Relation with DNA...

  • BRCA2 Research Is On a Fast Track to the Clinic. Nelson, Nancy J. // JNCI: Journal of the National Cancer Institute;10/21/98, Vol. 90 Issue 20, p1502 

    Presents information on gene research, with reference to the breast cancer susceptibility gene BRCA2. Problems associated with translating the gene's function into effective therapy; Reference to the cloning of genes; When the breast cancer susceptibility gene BRCA1 was cloned; Function of...

  • The genetic moral code. Gore, Al // Advocate;03/31/98, Issue 756, p9 

    Encourages the use of advances in genetic research for positive rather than destructive outcomes. Impetus to ensure that advances in genetics are used properly; Reason women do not get genetic testing for susceptibility to breast cancer; Information about the proposed legislation for the...

  • New Breast Cancer Gene Associations Found. Luntz, Stephen // Australasian Science;Dec2012, Vol. 33 Issue 10, p8 

    The article discusses a study by the Peter MacCallum Cancer Center published in a "PLOS Genetics" paper about two genes with variations that were found to be associated with breast cancer. These are the FANCC and BLM gene variations which are said to be associated with 1% of breast cancer....

  • Volumetric Mammographic Density: Heritability and Association With Breast cancer Susceptibility loci. Brand, Judith S.; Humphreys, Keith; Thompson, Deborah J.; Jingmei Li; Eriksson, Mikael; Hall, Per; Czene, Kamila // JNCI: Journal of the National Cancer Institute;12/10/2014, Vol. 106 Issue 12, p1 

    Background Mammographic density is a strong heritable trait, but data on its genetic component are limited to area-based and qualitative measures. We studied the heritability of volumetric mammographic density ascertained by a fully-automated method and the association with breast cancer...

  • The Effects of Soy Supplementation on Gene Expression in Breast Cancer: A Randomized Placebo-Controlled Study. Shike, Moshe; Doane, Ashley S.; Russo, Lianne; Cabal, Rafael; Reis-Filho, Jorge S.; Gerald, William; Cody, Hiram; Khanin, Raya; Bromberg, Jacqueline; Norton, Larry // JNCI: Journal of the National Cancer Institute;Sep2014, Vol. 106 Issue 9, p1 

    Background There are conflicting reports on the impact of soy on breast carcinogenesis. This study examines the effects of soy supplementation on breast cancer-related genes and pathways. Methods Women (n = 140) with early-stage breast cancer were randomly assigned to soy protein supplementation...

  • Plasticity of BRCA2 Function in Homologous Recombination: Genetic Interactions of the PALB2 and DNA Binding Domains. Siaud, Nicolas; Barbera, Maria A.; Egashira, Akinori; Lam, Isabel; Christ, Nicole; Schlacher, Katharina; Bing Xia; Jasin, Maria // PLoS Genetics;Dec2011, Vol. 7 Issue 12, Special section p1 

    The breast cancer suppressor BRCA2 is essential for the maintenance of genomic integrity in mammalian cells through its role in DNA repair by homologous recombination (HR). Human BRCA2 is 3,418 amino acids and is comprised of multiple domains that interact with the RAD51 recombinase and other...

  • HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study. Zagouri, Flora; Sergentanis, Theodoros; Gazouli, Maria; Tsigginou, Alexandra; Dimitrakakis, Constantine; Papaspyrou, Irene; Eleutherakis-Papaiakovou, Evaggelos; Chrysikos, Dimosthenis; Theodoropoulos, George; Zografos, George; Antsaklis, Aris; Dimopoulos, Athanassios-Meletios; Papadimitriou, Christos // Molecular Biology Reports;Dec2012, Vol. 39 Issue 12, p10873 

    This case control study aims to investigate the role of HSP90 Gln488His (C > G), HSP70-2 P1/P2, HIF-1 alpha C1772T and HSPA8 intronic 1541-1542delGT polymorphisms as potential risk factors and/or prognostic markers for breast cancer. 113 consecutive incident cases of histologically confirmed...

  • Pharmacogenomics of endocrine therapy in breast cancer. Ingle, James N // Journal of Human Genetics;Jun2013, Vol. 58 Issue 6, p306 

    The most important modality of treatment in the two-thirds of patients with an estrogen receptor (ER)-positive early breast cancer is endocrine therapy. In postmenopausal women, options include the selective ER modulators (SERMs), tamoxifen and raloxifene, and the 'third-generation' aromatase...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics